On September 5, 2023 Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, reported that Joseph Ferra, Chief Executive Officer of Elevation Oncology, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 12:00 pm ET (Press release, Elevation Oncology, SEP 5, 2023, https://elevationoncology.com/elevation-oncology-to-present-at-the-h-c-wainwright-25th-annual-global-investment-conference/?utm_source=rss&utm_medium=rss&utm_campaign=elevation-oncology-to-present-at-the-h-c-wainwright-25th-annual-global-investment-conference [SID1234634884]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast and replay of the event will be available on the Events page of the Company’s Investor Relations website at View Source